The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
|Videos|June 16, 2020
Contagion Live News Network: Improving COVID-19 Data Collection
Author(s)Contagion® Editorial Staff
Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.
Advertisement
Given there is not a clear international standard for electronic health records, one of the challenges in the early
In an interview with Contagion, the Academic Director of the Medical Industry Leadership Institute at the University of Minnesota discussed the value of data in pandemic response and analysis—and what went wrong in March.
In other coronavirus news, the FDA has now issued an Emergency Use Authorization for a COVID-19 Predictive Analytics Platform.
In a press release, AI researchers from CLEEW Med described using machine-learning as an aid in clinical assessment to evaluate risk for respiratory failure and hemodynamic instability.
For more on these stories, and for clinically relevant news concerning all infectious disease conditions, visit Contagionlive.com
Advertisement
Related to this article
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Advertisement
Advertisement